Search Within

Ronak Hasmukh Shah

  1. "Human Oncology and Pathogenesis Program"
Formats
  1. Meeting Abstract (36)
  2. Journal Article (30)
  3. Research Letter (2)
Groups
  1. GSK Faculty (68)
  2. Human Oncology and Pathogenesis Program (68)
  3. Center for Molecular Imaging and Biotechnology (CMIB) (67)
  4. Department of Pathology and Laboratory Medicine (67)
  5. Department of Medicine (49)
  6. Solid Tumor Oncology Division (47)

More Groups

People
  1. Michael Berger (65)
  2. David Solit (27)
  3. Sasinya Scott (21)
  4. Marc Ladanyi (17)
  5. Gopakumar Iyer (14)
  6. Dean Bajorin (13)

More People

Years
  1. 2025 (2)
  2. 2024 (7)
  3. 2023 (8)
  4. 2022 (3)
  5. 2021 (1)
  6. 2020 (2)

More Years

Publications
  1. Journal of Clinical Oncology (11)
  2. Journal of Molecular Diagnostics (9)
  3. Modern Pathology (9)
  4. Laboratory Investigation (7)
  5. Clinical Cancer Research (4)
  6. JCO Precision Oncology (3)

More Publications

Publishers
  1. Nature Publishing Group (15)
  2. American Society of Clinical Oncology (14)
  3. Elsevier Science, Inc. (12)
  4. Nature Research (9)
  5. American Association for Cancer Research (6)
  6. American Medical Association (2)

More Publishers

Results (68)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical and genomic landscape of FGFR3-altered urothelial carcinoma and treatment outcomes with erdafitinib: A real-world experience
    Journal Article

    Guercio, B. J.; Sarfaty, M.; Teo, M. Y.; Ratna, N.; Duzgol, C.; Funt, S. A.; Lee, C. H.; Aggen, D. H.; Regazzi, A. M.; Chen, Z.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: A single-arm, single-centre, phase 2 trial
    Journal Article

    Cytryn, S. L.; Moy, R. H.; Cowzer, D.; Shah, R. H.; Chou, J. F.; Joshi, S. S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • ctDNA analysis of NTRK fusion and mechanisms of acquired resistance to TRK inhibitors
    Meeting Abstract

    Sivaprakasam, K.; Harada, G.; Choudhury, N. J.; Savin, C.; Shah, R. H.; Berger, M. F.; Drilon, A. E.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Assessing the utility of a cell-free tumor (ct)DNA assay (MSK-ACCESS) in patients (pts) with node-positive (N+) muscle-invasive bladder cancer (MIBC) undergoing neoadjuvant chemotherapy (NAC)
    Meeting Abstract

    Katims, A. B.; Lenis, A. T.; Shah, R. H.; Chu, C. E.; Ratna, N.; Regazzi, A. M.; Pietzak, E. J.; Aggen, D. H.; Funt, S. A.; Teo, M. Y.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Antitumour activity of neratinib in patients with HER2-mutant advanced biliary tract cancers
    Journal Article

    Harding, J. J.; Piha-Paul, S. A.; Shah, R. H.; Murphy, J. J.; Cleary, J. M.; Shapiro, G. I.; Quinn, D. I.; Braña, I.; Moreno, V.; Borad, M.; more...
    Nature Communications (2023)

    Fulltext@MSK | Save
  • Next-generation sequencing (NGS) of circulating cell-free DNA (cfDNA) in advanced pancreatic neuroendocrine neoplasms (PanNENs)
    Meeting Abstract

    Cowzer, D.; Shah, R. H.; Punn, S.; Fiedler, L.; DeMore, A.; Chou, J. F.; Capanu, M.; Berger, M. F.; Reidy-Lagunes, D.; Raj, N. P.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • High-sensitivity mutation analysis of cell-free DNA for disease monitoring in endometrial cancer
    Journal Article

    Ashley, C. W.; Selenica, P.; Patel, J.; Wu, M.; Nincevic, J.; Lakhman, Y.; Zhou, Q.; Shah, R. H.; Berger, M. F.; Da Cruz Paula, A.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • Cell-free DNA analysis as a molecular tool to monitor response to immune checkpoint inhibition in endometrial cancer
    Meeting Abstract

    Manning-Geist, B.; Patel, J. A. A.; Marra, A.; Da Cruz Paula, A.; Hanlon, E. J.; Abu-Rustum, N.; Shah, R. H.; Berger, M. F.; Hensley, M. L.; Zamarin, D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Targeting HER2 mutation-positive advanced biliary tract cancers with neratinib: Final results from the phase 2 SUMMIT basket trial
    Meeting Abstract

    Harding, J. J.; Piha-Paul, S. A.; Shah, R. H.; Cleary, J. M.; Quinn, D. I.; Brana, I.; Moreno, V.; Borad, M. J.; Loi, S.; Spanggaard, I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Next-generation sequencing (NGS) of circulating cell-free DNA (cfDNA) in patients (pts) with advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Cowzer, D.; White, J. B.; Chen, P. J.; Kim, T. H.; Khalil, D.; El Dika, I. H.; Chou, J. F.; Yaqubie, A.; Light, J. S.; Shia, J.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save